Page last updated: 2024-11-08

folicanthine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

folicanthine: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID604246
CHEBI ID38974
MeSH IDM0511876

Synonyms (7)

Synonym
1,1',8,8'-tetramethyl-2,2',3,3',8,8',8a,8a'-octahydro-1h,1'h-3a,3a'-bipyrrolo[2,3-b]indole
CHEBI:38974
folicanthine
8b-(3,4-dimethyl-2,3a-dihydro-1h-pyrrolo[2,3-b]indol-8b-yl)-3,4-dimethyl-2,3a-dihydro-1h-pyrrolo[2,3-b]indole
calycanthidine, 1'-methyl-
UEOHDZULNTUKEK-UHFFFAOYSA-N
Q27118071
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (3)

ClassDescription
calycanthaceous alkaloidAny indole alkaloid obtained by the oxidative coupling two indole nuclei at the beta-position. Found commonly in the plants of the family calycanthaceae.
aminalCompounds having two amino groups bonded to the same carbon, R2C(NR2)2.
organonitrogen heterocyclic compoundAny organonitrogen compound containing a cyclic component with nitrogen and at least one other element as ring member atoms.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (11)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (18.18)29.6817
2010's9 (81.82)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other11 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]